國立虎尾科技大學 |

Language: English

Back

Drug targets in cellular processes o...

Tuli, Hardeep Singh.

Drug targets in cellular processes of cancer : = from nonclinical to preclinical models /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Drug targets in cellular processes of cancer :/ Hardeep Singh Tuli, editor.
Reminder of title:	from nonclinical to preclinical models /
remainder title:	From nonclinical to preclinical models
other author:	Tuli, Hardeep Singh.
Published:	Singapore :Springer, : 2020.,
Description:	xiii, 228 p. :ill. (some col.) ; : 24 cm.;
Subject:	Cancer - Chemotherapy. -
ISBN:	9789811575853 (hbk.) :

Drug targets in cellular processes of cancer : = from nonclinical to preclinical models /
Drug targets in cellular processes of cancer :from nonclinical to preclinical models /From nonclinical to preclinical modelsHardeep Singh Tuli, editor. - Singapore :Springer,2020. - xiii, 228 p. :ill. (some col.) ;24 cm.

Includes bibliographical references.

Chapter 1. History of oncotherapies in cancer biology -- Chapter 2. Electrochemical Sensors and Biosensors for the Detection of Cancer Biomarkers and Drugs -- Chapter 3. Cell cycle arrest: An impending therapeutic strategy to curb cancer -- Chapter 4. Apoptotic cell death: important cellular process as chemotherapeutic target -- Chapter 5. Regulatory roles of autophagy in cancer -- Chapter 6. ROS and Oxidative Stress in Cancer: Recent Advances -- Chapter 7. Inflammatory mediators: Potential drug targets in cancer -- Chapter 8. Pharmacologic modulation of the immune response against tumours in the elderly. Chapter 9. Angiogenesis: A Therapeutic Target for Cancer -- Chapter 10. Metastasis: A major driver of cancer pathogenesis -- Chapter 11. Designing Personalized and Innovative Novel Drug Therapies For Cancer Treatment.

This book explores potential cellular drug targets for cancer therapy. The first couple of chapters describe conventional treatment (radiotherapy, chemotherapy, and immunotherapy) & detection (biosensors) strategies for cancer. In contrast, the subsequent chapters address the role of cyclin-dependent kinases and cell cycle regulatory proteins in the growth of cancer cells and their potential as target for cancer treatment. The book then discusses the regulation of various pro-apoptotic and anti-apoptotic proteins via chemotherapeutic drugs. In addition, it examines the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells. It subsequently reviews the role of reactive oxygen (ROS) species during carcinogenesis and during chemotherapy, and the potential of anti-inflammatory routes for the development of new therapeutic modulators. Lastly, it describes therapeutic strategies that target the tumor microenvironment and various angiogenic pathways for the treatment of cancer and to develop personalized medicine. Given its scope, the book is valuable resource for oncologists, cancer researchers, clinicians, and pharmaceutical industry personnel.

ISBN: 9789811575853 (hbk.) :NT4600 Subjects--Topical Terms:

645264
Cancer
--Chemotherapy.

LC Class. No.: RC268.4

Dewey Class. No.: 616.99/4

Drug targets in cellular processes of cancer : = from nonclinical to preclinical models /
LDR:02901cam a2200241 a 4500 001 1037611
003 OCoLC
005 20201225093704.2
008 211013s2020 si a b 000 0 eng d
020 $a 9789811575853 (hbk.) : $c NT4600
020 $z 9789811575860 (ebk.)
020 $z 981157586X (ebk.)
035 $a (OCoLC)1203181839 $z (OCoLC)1198558852 $z (OCoLC)1202468059 $z (OCoLC)1226202222
035 $a 1203181839
040 $a EQF $b eng $e rda $c EQF $d OCLCO $d YDX $d GW5XE $d EBLCP $d N$T $d OCLCO $d UKAHL $d OCLCF $d S2H
050 # 4 $a RC268.4
082 0 4 $a 616.99/4 $2 23
245 0 0 $a Drug targets in cellular processes of cancer : $b from nonclinical to preclinical models / $c Hardeep Singh Tuli, editor.
246 3 0 $a From nonclinical to preclinical models
260 # $a Singapore : $b Springer, $c 2020.
300 $a xiii, 228 p. : $b ill. (some col.) ; $c 24 cm.
504 $a Includes bibliographical references.
505 0 # $a Chapter 1. History of oncotherapies in cancer biology -- Chapter 2. Electrochemical Sensors and Biosensors for the Detection of Cancer Biomarkers and Drugs -- Chapter 3. Cell cycle arrest: An impending therapeutic strategy to curb cancer -- Chapter 4. Apoptotic cell death: important cellular process as chemotherapeutic target -- Chapter 5. Regulatory roles of autophagy in cancer -- Chapter 6. ROS and Oxidative Stress in Cancer: Recent Advances -- Chapter 7. Inflammatory mediators: Potential drug targets in cancer -- Chapter 8. Pharmacologic modulation of the immune response against tumours in the elderly. Chapter 9. Angiogenesis: A Therapeutic Target for Cancer -- Chapter 10. Metastasis: A major driver of cancer pathogenesis -- Chapter 11. Designing Personalized and Innovative Novel Drug Therapies For Cancer Treatment.
520 # $a This book explores potential cellular drug targets for cancer therapy. The first couple of chapters describe conventional treatment (radiotherapy, chemotherapy, and immunotherapy) & detection (biosensors) strategies for cancer. In contrast, the subsequent chapters address the role of cyclin-dependent kinases and cell cycle regulatory proteins in the growth of cancer cells and their potential as target for cancer treatment. The book then discusses the regulation of various pro-apoptotic and anti-apoptotic proteins via chemotherapeutic drugs. In addition, it examines the molecular mechanisms that are critical for mediating autophagic cell death in cancer cells. It subsequently reviews the role of reactive oxygen (ROS) species during carcinogenesis and during chemotherapy, and the potential of anti-inflammatory routes for the development of new therapeutic modulators. Lastly, it describes therapeutic strategies that target the tumor microenvironment and various angiogenic pathways for the treatment of cancer and to develop personalized medicine. Given its scope, the book is valuable resource for oncologists, cancer researchers, clinicians, and pharmaceutical industry personnel.
650 # 0 $a Cancer $x Chemotherapy. $3 645264
650 # 0 $a Cancer $x Molecular aspects. $3 668357
650 # 0 $a Cancer $x Research. $3 783845
650 # 0 $a Drug targeting. $3 581035
700 1 # $a Tuli, Hardeep Singh. $e editor. $3 1326764